# Molina Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2022

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-Q
- Filed: 2022-04-28
- Accepted by EDGAR: Apr 28, 2022, 12:03 ET
- Period: 2022-03-31
- Accession: 0001179929-22-000080
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992922000080/moh-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992922000080/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $7.77bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2022-01-01 to 2022-03-31 | $6.56bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months, 2022-01-01 to 2022-03-31 | $372.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-01-01 to 2022-03-31 | $28.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | $86.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | $258.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-01-01 to 2022-03-31 | $4.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-01-01 to 2022-03-31 | $4.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-01-01 to 2022-03-31 | 58,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-01-01 to 2022-03-31 | $363.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-01-01 to 2022-03-31 | $23.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2022-01-01 to 2022-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-03-31 | $4.80bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $10.15bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $12.36bn | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $7.04bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-03-31 | $9.57bn | us-gaap:Liabilities |
| Long-term debt | at 2022-03-31 | $2.17bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2022-03-31 | $2.79bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992922000080/moh-20220331.htm

Filed Apr 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001179929-22-000080. Last ingested by Listed: Nov 10, 2026, 17:39 ET. No prices; not investment advice.